[URINARY ANOMALIES IN PATIENTS UNDER LONG-TERM TREATMENT WITH CORTISONE-LIKE DRUGS].
D001249:Asthma; D002128:Calcium Metabolism Disorders; D003348:Cortisone; D004906:Erythrocyte Count; D007674:Kidney Diseases; D007958:Leukocyte Count; D008775:Methylprednisolone; D010760:Phosphorus Metabolism Disorders; D011239:Prednisolone; D011241:Prednisone / Q000009:adverse effects*; D014116:Toxicology; D014221:Triamcinolone; D014556:Urine
D014221:Triamcinolone; D011239:Prednisolone; D003348:Cortisone; D011241:Prednisone; D008775:Methylprednisolone
ASTHMA; CALCIUM METABOLISM DISORDERS; ERYTHROCYTE COUNT; KIDNEY DISEASES; LEUKOCYTE COUNT; METHYLPREDNISOLONE; PHOSPHORUS METABOLISM DISORDERS; PREDNISOLONE; PREDNISONE TOXICOLOGY; TOXICOLOGIC REPORT; TRIAMCINOLONE; URINE
ANOMALIES URINAIRES CHEZ DES MALADES EN TRAITEMENT CORTISONIQUE AU LONG COURS.